Veterinary medicines European public assessment report (EPAR): Versican Plus Pi/L4, canine parainfluenza virus and Leptospira, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Versican Plus Pi/L4, canine parainfluenza virus and Leptospira, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Versican Plus L4, Canine leptospirosis vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Versican Plus L4, Canine leptospirosis vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Innovax-ND-IBD, Newcastle disease, infectious bursal disease and Marek's disease vaccine (live recombinant), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Innovax-ND-IBD, Newcastle disease, infectious bursal disease and Marek's disease vaccine (live recombinant), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Vaxxitek HVT+IBD, Infectious bursal disease and Marek's disease vaccine (live recombinant), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Vaxxitek HVT+IBD, Infectious bursal disease and Marek's disease vaccine (live recombinant), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Poulvac E. coli, Escherichia coli aroA gene deleted, type O78, strain EC34195 (live), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Poulvac E. coli, Escherichia coli aroA gene deleted, type O78, strain EC34195 (live), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Porcilis PCV M Hyo, porcine circovirus type 2 ORF2 subunit antigen,mycoplasma hyopneumoniae vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Porcilis PCV M Hyo, porcine circovirus type 2 ORF2 subunit antigen,mycoplasma hyopneumoniae vaccine (inactivated), Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.